SVP Clinical Development Jeffrey Wiezorek sold $82K of Kite Pharma, Inc.

Sold$82,214

$54.81Price

1,500Shares

−9%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Mon, Oct 3. Filed Wed, Oct 5, 3:44 PM ET, during the session. Not investment advice.